Showing 410 results

Filters Content type: News, Editors' picks, About HIV Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Side effects

Switching from efavirenz to etravirine improves mood and sleep

News
7 December 2010
Changing treatment

ZAMBIA: Ephraim Banda, The third-line drugs we don't have

Editor's pick
IRIN Plus News
23 November 2010
Changing treatment

No evidence that patients taking long-term efavirenz want to switch to etravirine

News
18 November 2010
Changing treatment

All HIV patients to get second-line treatment free

Editor's pick
Times of India
13 November 2010
New & experimental HIV treatments

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

News
10 November 2010
People with limited treatment options

Darunavir working well for highly treatment-experienced patients in Switzerland

News
25 October 2010
Bone & joint problems

Switch from efavirenz or AZT associated with improvement in vitamin D levels

News
20 October 2010
Changing treatment

Adding drugs to already successful HIV treatment doesn't reduce viral load further

News
15 October 2010
Changing treatment

Targeted viral load tests in India prevent switches to second-line ARVs for one in four

News
13 October 2010
Resistance

New computer modelling system predicts responses to HIV and AIDS treatments

Editor's pick
Science Daily
7 October 2010
Changing treatment

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Generic Version Of Reyataz® Capsules HIV Treatment

Editor's pick
HIV / AIDS News From Medical News Today
6 October 2010
Changing treatment

Switch to nevirapine can happen at any CD4 count, says European drug regulator

News
17 September 2010
Cardiovascular disease

ICAAC: Switch to HIV combo pill may improve lipids

Editor's pick
MedPage Today
16 September 2010
Changing treatment

AFRICA/ASIA: Worrying rates of second-line treatment failure

Editor's pick
IRIN Plus News
4 August 2010
Changing treatment

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

News
22 July 2010
Neurological & cognitive problems

Maraviroc potentially useful if neurological disease is present

News
15 July 2010
HIV treatment

Laboratory monitoring of ART could be cost-effective for many countries

News
3 June 2010
Changing treatment

Protease inhibitor monotherapy in clinical practice: valid option for undetectable patients

News
27 April 2010
Viral load

Viral load testing: once a year proves adequate in lower-income Asia study

News
9 April 2010
Changing treatment

Resistance tests useful for patients with very low viral loads

News
8 April 2010
Changing treatment

Once-daily darunavir effective and less toxic than twice-daily in experienced patients without prior darunavir resistance: ODIN

News
18 February 2010
Changing treatment

Second-line ART in South Africa shows good results

News
1 February 2010
Starting treatment

New resistance becoming rarer as more patients achieve undetectable HIV viral load

News
5 January 2010
Resistance

Most NNRTI-experienced patients in southern Africa will benefit from etravirine

News
18 December 2009